Some general info from yahoo:
Sanguine Corporation OTC BB : SGNC
Address: 101 East Green Street, #11
Pasadena, CA 91105
Phone: (626) 405-0079
Industry: Biotechnology & Drugs
Sector: Healthcare
Employees: 2
Officers: Thomas C. Drees Ph.D., Chmn./Pres./CEO
David E. Nelson, CFO
Anthony G. Hargreaves, VP/Secy./Treas.
Business Summary
Sanguine Corporation, a development stage company, is engaged in the development of a synthetic red blood cell product called PHER-02, a second generation version of Fluosol, the only FDA-approved synthetic blood product to date. For the three months ended 3/31/98, the Company reported no revenues. Net loss fell 38% to $37 thousand. Lower loss reflects lower research and development expenses and the absence of $12 thousand in consultant fees.
Statistics at a Glance -- SGNC Last Updated: June 19, 1998
Price and Volume
(updated June 19, 1998)
52-Week Low $0.188
Recent Price $0.844
52-Week High $1.031
Beta N/A
Daily Volume (3-month avg) 955
Share-Related Items
Market Capitalization $17.7M
Shares Outstanding 21.0M
Float 7.80M
Dividend Information
Annual Dividend none
Per-Share Data
Book Value (mrq) -$0.03
Earnings (ttm) -$0.01
Sales N/A
Cash N/A
Valuation Ratios
Price/Book N/A
Price/Earnings N/A
Price/Sales N/A
Income Statements
Net Income (ttm) -$144.0K
Sales N/A
Profitability
Profit Margin N/A
Management Effectiveness
Return on Assets (ttm) -1800.00%
Return on Equity N/A
Financial Strength
Current Ratio N/A
Total Debt/Equity N/A
See the Profile FAQ for a description of each item above; K = thousands; M = millions; mrq = most-recent quarter; ttm = trailing twelve months through Mar 31, 1998
|
